Switzerland: NIMGenetics advances international expansion plans with Gene Predictis acquisition

NIMGenetics Genomica y Medicina, a Spanish a biotechnological company specializing in the design and marketing of genetic diagnostic products and services, has completed the acquisition of Gene Predictis, a Swiss-based medical diagnostic company and leader in the field of preventive health and precision medicine. NIM is an Apposite Capital portfolio company. Since its foundation in…

You must be a HMI Subscriber to view this content.

Subscribe Now »